Stanley McClurg, MD
Otolaryngology · Merriam, KSNPI 1659531515
Payments from drug & device makers
Across 411 payments — averaging $323.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$108K
- Stryker$10K
- Intersect ENT, Inc.$7K
- Medtronic$2K
- Neurent Medical Limited$925
- Sanofi$895
- plus $4K from 27 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 130 | $108,135 |
| Stryker | 31 | $9,719 |
| Intersect ENT, Inc. | 50 | $7,298 |
| Medtronic | 4 | $1,929 |
| Neurent Medical Limited | 8 | $925 |
| Sanofi | 42 | $895 |
| GSK | 36 | $775 |
| Optinose US, Inc. | 38 | $639 |
| Acclarent, Inc | 11 | $591 |
| KARL Storz Endoscopy-america | 10 | $511 |
| Regeneron Healthcare Solutions, Inc. | 17 | $438 |
| Integra Lifesciences Corporation | 2 | $295 |
| Olympus America Inc. | 5 | $197 |
| Next Science LLC | 1 | $160 |
| Smith+Nephew | 1 | $108 |
| Arrinex, Inc. | 1 | $64 |
| AstraZeneca | 2 | $50 |
| Merck | 3 | $45 |
| Baudax Bio Inc. | 2 | $35 |
| Davol Inc. | 1 | $32 |
| AbbVie | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $32 |
| Pfizer | 2 | $30 |
| Globus Medical | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $25 |
| Ambu Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Vertex | 1 | $24 |
| Amgen | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Bolder Surgical, LLC | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$133,147 in reported general payments places this provider in the 95th percentile of 87 otolaryngology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other otolaryngology in Merriam
- Nicholas WirtzMerriam$14K
- Katherine AberleMerriam$4K
- Jason ShowmakerMerriam$2K
- Kyle KimuraMerriam$1K
- Hinrich StaeckerKansas City$1.2M
- Christopher LarsenKansas City$159K
- Douglas CowanLeawood$32K
- Jennifer VillwockKansas City$26K
- David RudmanOverland Park$18K
- Meha FoxKansas City$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.